Metraipolis › archive › dc_98433f92b467

Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:41901569

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41901569
DOI
10.3390/medicina62030488
License (as archived)
solo-consultazione
Archived
2026-11-05T03:36:24.179Z
SHA-256 of the archived text
3b4fe00c01c05e55b337f1038e1f15b492758e294b0a2f3f10bffe71aedeab37
Stable URL of this page
https://metraipolis.com/documento/dc_98433f92b467

How to cite

Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:41901569 — Europe PMC (en), https://europepmc.org/article/MED/41901569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98433f92b467 (Metraipolis archive dc_98433f92b467, sha256 3b4fe00c01c05e55b337f1038e1f15b492758e294b0a2f3f10bffe71aedeab37)
BibTeX
@misc{dc98433f92b467,
  title = {Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:41901569},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41901569},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98433f92b467; sha256 3b4fe00c01c05e55b337f1038e1f15b492758e294b0a2f3f10bffe71aedeab37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41901569. Agents can read the archived copy with the MCP tool read_document.